We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1026
Beam Therapeutics
BEAM
$2.7B
$9K ﹤0.01%
115
+6
+6% +$571
IOVA icon
1027
Iovance Biotherapeutics
IOVA
$2.1B
$9K ﹤0.01%
291
+15
+5% +$622
SAGE
1028
DELISTED
Sage Therapeutics
SAGE
$9K ﹤0.01%
116
+18
+18% +$1.48K
TPTX
1029
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9K ﹤0.01%
95
+4
+4% +$476
CBPO
1030
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$9K ﹤0.01%
77
+4
+5% +$473
ACAD icon
1031
Acadia Pharmaceuticals
ACAD
$4.45B
$8K ﹤0.01%
317
+18
+6% +$792
BNS icon
1032
Scotiabank
BNS
$108B
$8K ﹤0.01%
130
KB icon
1033
KB Financial Group
KB
$40.6B
$8K ﹤0.01%
170
-615
-78% -$25.6K
ARNA
1034
DELISTED
Arena Pharmaceuticals Inc
ARNA
$8K ﹤0.01%
119
+10
+9% +$769
WPG
1035
DELISTED
Washington Prime Group Inc.
WPG
$8K ﹤0.01%
3,513
+3
+0.1% +$22
AGIO icon
1036
Agios Pharmaceuticals
AGIO
$2.14B
$7K ﹤0.01%
138
+8
+6% +$396
APLS
1037
DELISTED
Apellis Pharmaceuticals
APLS
$7K ﹤0.01%
159
+17
+12% +$804
INSM icon
1038
Insmed
INSM
$22.6B
$7K ﹤0.01%
204
+12
+6% +$459
NKTR icon
1039
Nektar Therapeutics
NKTR
$2.39B
$7K ﹤0.01%
24
+2
+9% +$622
PTCT icon
1040
PTC Therapeutics
PTCT
$6.25B
$7K ﹤0.01%
139
+11
+9% +$653
RVMD icon
1041
Revolution Medicines
RVMD
$39.1B
$7K ﹤0.01%
143
+18
+14% +$807
SWTX
1042
DELISTED
SpringWorks Therapeutics
SWTX
$7K ﹤0.01%
92
VCYT icon
1043
Veracyte
VCYT
$4.44B
$7K ﹤0.01%
133
+24
+22% +$1.38K
CCXI
1044
DELISTED
ChemoCentryx, Inc.
CCXI
$7K ﹤0.01%
137
+7
+5% +$421
ALKS icon
1045
Alkermes
ALKS
$8.47B
$6K ﹤0.01%
299
ALXO icon
1046
ALX Oncology
ALXO
$268M
$6K ﹤0.01%
79
+9
+13% +$708
ARVN icon
1047
Arvinas
ARVN
$529M
$6K ﹤0.01%
94
+18
+24% +$1.38K
EDIT icon
1048
Editas Medicine
EDIT
$402M
$6K ﹤0.01%
133
+16
+14% +$912
KYNB
1049
Kyntra Bio
KYNB
$28.2M
$6K ﹤0.01%
7
PCRX icon
1050
Pacira BioSciences
PCRX
$1.05B
$6K ﹤0.01%
82

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.